TY - JOUR
T1 - Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating
T2 - Involvement of pallidotegmental neurons
AU - Mizoguchi, Hiroyuki
AU - Arai, Sawako
AU - Koike, Hiroyuki
AU - Ibi, Daisuke
AU - Kamei, Hiroyuki
AU - Nabeshima, Toshitaka
AU - Kim, Hyoung Chun
AU - Takuma, Kazuhiro
AU - Yamada, Kiyofumi
N1 - Funding Information:
Acknowledgments This study was supported in part by a Grant-in-aid for Scientific Research (No.19390062) from the Japan Society for the Promotion of Science and by grants for the 21st century COE program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Smoking Research Foundation, Japan; JSPS and KOSEF under the Japan-Korea Basic Scientific Cooperation Program; the Academic Frontier Project for Private Universities, matching fund subsidy from MEXT, 2007–2011, Research on the Risk of Chemical Substances, Health and Labour Science Research Grants supported by the Ministry of Health, Labour and Welfare, and JST, CREST, and GCOE.
PY - 2009/12
Y1 - 2009/12
N2 - Introduction: We have previously found that a disruption to prepulse inhibiton (PPI) induced by methamphetamine (METH) is associated with impaired functioning of pallidotegmental neurons, which play a crucial role in PPI of the startle reflex, through the activation of gamma-aminobutyric acid type B receptors in pedunculopontine tegmental neurons in mice. Objectives: Here, we examined the effect of nicotine on METH-induced impairment of PPI of the startle reflex focusing on dysfunctional pallidotegmental neurons and the neural system. Results: Nicotine (0.15-0.5 mg/kg) ameliorated the deficit in PPI induced by acute METH, and the ameliorating effect of nicotine was antagonized by nicotinic receptor antagonists such as methyllycaconitine and dihydro-β-erythroidine. The acute METH-induced disruption of PPI was accompanied by suppression of c-Fos expression in the lateral globus pallidus (LGP) as well as its induction in the caudal pontine reticular nucleus (PnC) in mice subjected to the PPI test. Nicotine-induced amelioration of PPI deficits in METH-treated mice was accompanied by a reversal of the changes in c-Fos expression in both the LGP and PnC to the basal level. Conclusions: Nicotine is effective in ameliorating the impairment of PPI caused by METH, which may be associated with normalization of the pallidotegmental neurons.
AB - Introduction: We have previously found that a disruption to prepulse inhibiton (PPI) induced by methamphetamine (METH) is associated with impaired functioning of pallidotegmental neurons, which play a crucial role in PPI of the startle reflex, through the activation of gamma-aminobutyric acid type B receptors in pedunculopontine tegmental neurons in mice. Objectives: Here, we examined the effect of nicotine on METH-induced impairment of PPI of the startle reflex focusing on dysfunctional pallidotegmental neurons and the neural system. Results: Nicotine (0.15-0.5 mg/kg) ameliorated the deficit in PPI induced by acute METH, and the ameliorating effect of nicotine was antagonized by nicotinic receptor antagonists such as methyllycaconitine and dihydro-β-erythroidine. The acute METH-induced disruption of PPI was accompanied by suppression of c-Fos expression in the lateral globus pallidus (LGP) as well as its induction in the caudal pontine reticular nucleus (PnC) in mice subjected to the PPI test. Nicotine-induced amelioration of PPI deficits in METH-treated mice was accompanied by a reversal of the changes in c-Fos expression in both the LGP and PnC to the basal level. Conclusions: Nicotine is effective in ameliorating the impairment of PPI caused by METH, which may be associated with normalization of the pallidotegmental neurons.
UR - http://www.scopus.com/inward/record.url?scp=70449346280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449346280&partnerID=8YFLogxK
U2 - 10.1007/s00213-009-1651-z
DO - 10.1007/s00213-009-1651-z
M3 - Article
C2 - 19756526
AN - SCOPUS:70449346280
SN - 0033-3158
VL - 207
SP - 235
EP - 243
JO - Psychopharmacology
JF - Psychopharmacology
IS - 2
ER -